Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mott

Showing results (121-130 of 254) with videos related to

Pageof 26
Sort By:
Translational Andrology and Urology|July 12, 2026
Impact of age on the effectiveness of intravesical Bacillus Calmette‑Guérin and gemcitabine/docetaxel in treatment-naïve high-risk non‑muscle‑invasive bladder cancerMohamad Abou Chakra, Amanda A Myers, Kathryn A Marchetti, et al.
Journal of Cellular Biochemistry|June 22, 2010
Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaBJustin L Mott, Satoshi Kurita, Sophie C Cazanave, et al.
The Canadian Journal of Urology|August 11, 2021
Decreased testosterone recovery after androgen deprivation therapy for prostate cancerMargaret E Long, Andrew M Vitale, Sarah L Mott, et al.
BJU International|October 22, 2025
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Frontiers in Psychology|June 1, 2022
Characterizing Early Changes in Quality of Life in Young Women With Breast CancerHend M Al-Kaylani, Bradley T Loeffler, Sarah L Mott, et al.
Urologic Oncology|December 1, 2022
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancerPhani T Chevuru, Ian M McElree, Sarah L Mott, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
The American Journal of Clinical Nutrition|October 1, 1983
Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humansA C Tsai, E L Mott, G M Owen, et al.
European Urology Focus|June 27, 2025
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder CancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Journal of Cellular Biochemistry|January 4, 2022
Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signalingAndrew J Phillips, Marissa B Lobl, Yamnah A Hafeji, et al.
Pageof 26

Showing results (121-130 of 254) with videos related to

Sort By:
Pageof 26
Translational Andrology and Urology|July 12, 2026
Impact of age on the effectiveness of intravesical Bacillus Calmette‑Guérin and gemcitabine/docetaxel in treatment-naïve high-risk non‑muscle‑invasive bladder cancerMohamad Abou Chakra, Amanda A Myers, Kathryn A Marchetti, et al.
Journal of Cellular Biochemistry|June 22, 2010
Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaBJustin L Mott, Satoshi Kurita, Sophie C Cazanave, et al.
The Canadian Journal of Urology|August 11, 2021
Decreased testosterone recovery after androgen deprivation therapy for prostate cancerMargaret E Long, Andrew M Vitale, Sarah L Mott, et al.
BJU International|October 22, 2025
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Frontiers in Psychology|June 1, 2022
Characterizing Early Changes in Quality of Life in Young Women With Breast CancerHend M Al-Kaylani, Bradley T Loeffler, Sarah L Mott, et al.
Urologic Oncology|December 1, 2022
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancerPhani T Chevuru, Ian M McElree, Sarah L Mott, et al.
Antibiotics (Basel, Switzerland)|October 30, 2020
Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based ImmunotherapiesUmang Swami, Adithya Chennamadhavuni, Nicholas Borcherding, et al.
The American Journal of Clinical Nutrition|October 1, 1983
Effects of soy polysaccharide on gastrointestinal functions, nutrient balance, steroid excretions, glucose tolerance, serum lipids, and other parameters in humansA C Tsai, E L Mott, G M Owen, et al.
European Urology Focus|June 27, 2025
Extended Outcomes of Intravesical Valrubicin and Docetaxel as a Secondary Salvage Treatment for Recalcitrant High-risk Non-muscle-invasive Bladder CancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Journal of Cellular Biochemistry|January 4, 2022
Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signalingAndrew J Phillips, Marissa B Lobl, Yamnah A Hafeji, et al.
Pageof 26